Who is sponsoring NCT07241611?

NCT07241611 is sponsored by Mansoura University.

What drugs are being tested in NCT07241611?

Interventions in NCT07241611: Total laryngectomy.

What condition does NCT07241611 study?

NCT07241611 studies Malignant Tumor of the Larynx.

Is NCT07241611 still recruiting?

NCT07241611 is currently completed. Last updated 21 November 2025.

Last reviewed 2025-11-21 · How we verify

NCT07241611

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Cervical Fascia Flap in Decreasing the Incidence of Pharyngocutaneous Fistula After Total Laryngectomy

Completed NA Last updated 21 November 2025

What this trial tests

NA trial testing Total laryngectomy in Malignant Tumor of the Larynx in 50 participants. Completed in 30 September 2025.

Timeline

1 July 2024

Primary endpoint
30 September 2025

30 September 2025

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	1 July 2024
Primary completion	30 September 2025
Estimated completion	30 September 2025
Sites	1 location across Egypt

Drugs / interventions tested

Total laryngectomy

Conditions studied

Malignant Tumor of the Larynx — all drugs for Malignant Tumor of the Larynx →

Sponsor

Mansoura University

Who can join

Eligibility, any sex, with Malignant Tumor of the Larynx. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate the potential role of using the cervical fascia flap over the pharyngeal closure line to enhance healing and subsequently to decrease the incidence of pharyngocutaneous fistula after total laryngectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07241611 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 21 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07241611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing